TrialPain medicine (Malden, Mass.)2017

The MOBILE Study-A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain.

Daniel Bradford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.